Skip to Main Content

Paper Details

A Roundtable Discussion of the Breast Cancer Therapy Expert Group (BCTEG): Clinical Developments and Practice Guidance on Human Epidermal Growth Factor Receptor 2 (HER2)-positive Breast Cancer.
Clinical Breast Cancer
10
2020
BCTEG, Breast Cancer, HER2, HER2+, HER2+ breast cancer, HER2-positive (HER2+) breast cancer, Human, Human Epidermal Growth Factor Receptor 2, breast cancer, breast tumors, human epidermal growth factor receptor 2, lapatinib, neratinib, patients, pertuzumab, trastuzumab, tyrosine
Author NameAffiliation
Michael F PressUniversity of Southern California
  • 1 - 1

Datasets

Release 1.2